Details for New Drug Application (NDA): 207349
✉ Email this page to a colleague
NDA 207349 describes MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER, which is a drug marketed by B Braun Medical, Baxter Hlthcare Corp, Fresenius Kabi Usa, Hospira, Hq Spclt Pharma, and Pharmobedient, and is included in six NDAs. It is available from five suppliers. Additional details are available on the MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER profile page.
The generic ingredient in MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER is magnesium sulfate. There is one drug master file entry for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the magnesium sulfate profile page.
The generic ingredient in MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER is magnesium sulfate. There is one drug master file entry for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the magnesium sulfate profile page.
Summary for 207349
| Tradename: | MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER |
| Applicant: | Hq Spclt Pharma |
| Ingredient: | magnesium sulfate |
| Patents: | 0 |
Suppliers and Packaging for NDA: 207349
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 207349 | ANDA | WG Critical Care, LLC | 44567-410 | 44567-410-24 | 24 BAG in 1 CARTON (44567-410-24) / 100 mL in 1 BAG |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 1GM/100ML | ||||
| Approval Date: | Mar 2, 2016 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
